The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
07 05 2020
07 05 2020
Historique:
received:
14
10
2019
accepted:
24
03
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
24
11
2020
Statut:
epublish
Résumé
We investigated the role of dynamic changes of serum levels S100B protein in brain injury and poor outcome of sepsis. This is a prospective cohort study designed to include 104 adult patients with sepsis who are admitted to ICU from Jan 2015 to Aug 2016. Sepsis was defined as sepsis 3.0. Patients with a GCS score of <15, or at least one positive CAM-ICU score were thought to have brain dysfunction. 59 patients were diagnosed with SAE and the rest 45 patients were diagnosed with non-SAE. Serum S100B was measured on day 1 and 3 after ICU admission. Primary outcomes included brain dysfunction and 28-day/180-day mortality. The SAE group showed a significantly higher APACHE II score, SOFA scores, length of ICU stay, 28-day and 180-day mortality, serum S100B levels on day 1 and day 3. S100B levels on day 1 of 0.226 μg/L were diagnostic for SAE with 80.0% specificity and 66.1% sensitivity, and the area under (AUC) the curve was 0.728, S100B levels on day 3 of 0.144 μg/L were diagnostic for SAE with 84.44% specificity and 69.49% sensitivity, and the AUC was 0.819. In addition, the AUC for S100B on day 3 for predicting 180-day mortality was larger than for S100B on day 1 (0.731 vs. 0.611). Multiple logistic regression analysis showed that S100B3 (p = 0.001) but not S100B1 (p = 0.927) were independently correlated with SAE. Kaplan-Meier survival analysis showed that patients with S100B levels higher than 0.144 μg/L had a lower probability of survival at day 180. There were more patients with encephalopathy and a higher 28-day or 180-day mortality in the ΔS100B + group than in the ΔS100B- group. Multiple logistic regression analysis showed that SAE and IL-6 on day 3 were independently correlated with S100B dynamic increase. These findings suggest that elevated serum S100B levels on day 3 and the dynamic changes of serum S100B levels from day three to one were more associated with brain dysfunction and mortality than that on day 1 in patients with sepsis.
Identifiants
pubmed: 32382007
doi: 10.1038/s41598-020-64200-3
pii: 10.1038/s41598-020-64200-3
pmc: PMC7206038
doi:
Substances chimiques
Interleukin-6
0
S100 Calcium Binding Protein beta Subunit
0
S100B protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7718Références
Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801–810 (2016).
pubmed: 4968574
pmcid: 4968574
doi: 10.1001/jama.2016.0287
Zhang, L. N. et al. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011. Chin Med J (Engl) 125, 828–831 (2012).
Gofton, T. E. & Young, G. B. Sepsis-associated encephalopathy. Nat Rev Neurol 8, 557–566 (2012).
pubmed: 22986430
doi: 10.1038/nrneurol.2012.183
Schuler, A. et al. The Impact of Acute Organ Dysfunction on Long-Term Survival in Sepsis. Crit Care Med 46, 843–849 (2018).
pubmed: 29432349
pmcid: 5953770
doi: 10.1097/CCM.0000000000003023
Pandharipande, P. P. et al. Long-term cognitive impairment after critical illness. N Engl J Med 369, 1306–1316 (2013).
pubmed: 24088092
pmcid: 3922401
doi: 10.1056/NEJMoa1301372
Eidelman, L. A., Putterman, D., Putterman, C. & Sprung, C. L. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 275, 470–473 (1996).
pubmed: 8627969
Sharshar, T., Bozza, F. & Chrétien, F. Neuropathological processes in sepsis. Lancet Neurol 13, 534–536 (2014).
pubmed: 24849853
doi: 10.1016/S1474-4422(14)70064-X
Mazeraud, A. et al. Neuroanatomy and Physiology of Brain Dysfunction in Sepsis. Clin Chest Med 37, 333–345 (2016).
pubmed: 27229649
doi: 10.1016/j.ccm.2016.01.013
Sweis, R., Ortiz, J. & Biller, J. Neurology of Sepsis. Curr Neurol Neurosci Rep 16, 21 (2016).
pubmed: 26820754
doi: 10.1007/s11910-016-0623-z
Hughes, C. G. et al. Endothelial Activation and Blood-Brain Barrier Injury as Risk Factors for Delirium in Critically Ill Patients. Crit Care Med 44, e809–817 (2016).
pubmed: 27088157
pmcid: 4987204
doi: 10.1097/CCM.0000000000001739
Davies, D. C. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200, 639–646 (2002).
pubmed: 12162731
pmcid: 1570752
doi: 10.1046/j.1469-7580.2002.00065.x
Danielski, L. G. et al. Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis. Mol Neurobiol 55, 1045–1053 (2018).
pubmed: 28092082
doi: 10.1007/s12035-016-0356-7
Sharshar, T., Polito, A., Checinski, A. & Stevens, R. D. Septic-associated encephalopathy–everything starts at a microlevel. Crit Care 14, 199 (2010).
pubmed: 21067627
pmcid: 3219258
doi: 10.1186/cc9254
Jensen, R., Marshak, D. R., Anderson, C., Lukas, T. J. & Watterson, D. M. Characterization of human brain S100 protein fraction: amino acid sequence of S100 beta. J Neurochem 45, 700–705 (1985).
pubmed: 4031854
doi: 10.1111/j.1471-4159.1985.tb04048.x
Bloomfield, S. M., McKinney, J., Smith, L. & Brisman, J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 6, 121–138 (2007).
pubmed: 17522796
doi: 10.1007/s12028-007-0008-x
Thelin, E. P., Nelson, D. W. & Bellander, B. M. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir (Wien) 159, 209–225 (2017).
doi: 10.1007/s00701-016-3046-3
Monbailliu, T., Goossens, J. & Hachimi-Idrissi, S. Blood protein biomarkers as diagnostic tool for ischemic stroke: a systematic review. Biomark Med 11, 503–512 (2017).
pubmed: 28598212
doi: 10.2217/bmm-2016-0232
Derwall, M., Stoppe, C., Brücken, D., Rossaint, R. & Fries, M. Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study. Crit Care 13, R58 (2009).
pubmed: 19368739
pmcid: 2689505
doi: 10.1186/cc7785
Al Tmimi, L. et al. Serum protein S100 as marker of postoperative delirium after off-pump coronary artery bypass surgery: secondary analysis of two prospective randomized controlled trials. Clin Chem Lab Med 54, 1671–1680 (2016).
pubmed: 26943607
doi: 10.1515/cclm-2015-1012
Nguyen, D. N. et al. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med 34, 1967–1974 (2006).
pubmed: 16607230
doi: 10.1097/01.CCM.0000217218.51381.49
Hamed, S. A., Hamed, E. A. & Abdella, M. M. Septic encephalopathy: relationship to serum and cerebrospinal fluid levels of adhesion molecules, lipid peroxides and S-100B protein. Neuropediatrics 40, 66–72 (2009).
pubmed: 19809934
doi: 10.1055/s-0029-1231054
Nguyen, D. N. et al. Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO). Neurocrit Care 20, 367–374 (2014).
pubmed: 23860667
doi: 10.1007/s12028-013-9874-6
Weigand, M. A. et al. Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Anesthesiology 92, 905–907 (2000).
pubmed: 10719986
doi: 10.1097/00000542-200003000-00057
Anderson, B. J. et al. Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis. J Crit Care 36, 18–23 (2016).
pubmed: 27546742
pmcid: 5096992
doi: 10.1016/j.jcrc.2016.06.012
Piazza, O., Russo, E., Cotena, S., Esposito, G. & Tufano, R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth 99, 518–521 (2007).
pubmed: 17650519
doi: 10.1093/bja/aem201
Yao, B., Zhang, L. N., Ai, Y. H., Liu, Z. Y. & Huang, L. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res 39, 1263–1269 (2014).
pubmed: 24760429
doi: 10.1007/s11064-014-1308-0
Panni, J. K. & Panni, M. K. Changes in S100B levels rather than absolute values may be a better marker of severity of septic encephalopathy. Br J Anaesth 100, 419; author reply 419-420 (2008).
Nguyen, D. N. et al. Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock. Biomed Res Int 2014, 712742 (2014).
pubmed: 24883321
pmcid: 4022165
Ehler, J. et al. Diagnostic value of NT-proCNP compared to NSE and S100B in cerebrospinal fluid and plasma of patients with sepsis-associated encephalopathy. Neurosci Lett 692, 167–173 (2019).
pubmed: 30423400
doi: 10.1016/j.neulet.2018.11.014
Sonneville, R. et al. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med 43, 1075–1084 (2017).
pubmed: 28466149
doi: 10.1007/s00134-017-4807-z
van den Boogaard, M. et al. Endotoxemia-induced inflammation and the effect on the human brain. Crit Care 14, R81 (2010).
pubmed: 20444270
pmcid: 2911704
doi: 10.1186/cc9001
Zenaide, P. V. & Gusmao-Flores, D. Biomarkers in septic encephalopathy: a systematic review of clinical studies. Rev Bras Ter Intensiva 25, 56–62 (2013).
pubmed: 23887761
pmcid: 4031860
doi: 10.1590/S0103-507X2013000100011
Pfister, D. et al. Cerebral perfusion in sepsis-associated delirium. Crit Care 12, R63 (2008).
pubmed: 18457586
pmcid: 2481444
doi: 10.1186/cc6891
Pfister, D. et al. Intracranial pressure in patients with sepsis. Acta Neurochir Suppl 102, 71–75 (2008).
pubmed: 19388291
doi: 10.1007/978-3-211-85578-2_14
Hsu, A. A. et al. Neurological injury markers in children with septic shock. Pediatr Crit Care Med 9, 245–251 (2008).
pubmed: 18446104
doi: 10.1097/PCC.0b013e3181727b22
Jorge-Ripper, C. et al. Prognostic value of acute delirium recovery in older adults. Geriatr Gerontol Int 17, 1161–1167 (2017).
pubmed: 27436624
doi: 10.1111/ggi.12842
Ercole, A., Thelin, E. P., Holst, A., Bellander, B. M. & Nelson, D. W. Kinetic modelling of serum S100b after traumatic brain injury. BMC Neurol 16, 93 (2016).
pubmed: 27315805
pmcid: 4912776
doi: 10.1186/s12883-016-0614-3
Thelin, E. P., Nelson, D. W. & Bellander, B. M. Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury. Neurocrit Care 20, 217–229 (2014).
pubmed: 24146416
doi: 10.1007/s12028-013-9916-0
Lipcsey, M. et al. The brain is a source of S100B increase during endotoxemia in the pig. Anesth Analg 110, 174–180 (2010).
pubmed: 19897802
doi: 10.1213/ANE.0b013e3181c0724a
Zhang, L. N. et al. Diagnostic and Predictive Levels of Calcium-binding Protein A8 and Tumor Necrosis Factor Receptor-associated Factor 6 in Sepsis-associated Encephalopathy: A Prospective Observational Study. Chin Med J (Engl) 129, 1674–1681 (2016).
doi: 10.4103/0366-6999.185860
Feng, Q. et al. Characterization of Sepsis and Sepsis-Associated Encephalopathy. J Intensive Care Med 885066617719750 (2017).
Heming, N. et al. Neuroanatomy of sepsis-associated encephalopathy. Crit Care 21, 65 (2017).
pubmed: 28320461
pmcid: 5360026
doi: 10.1186/s13054-017-1643-z
Kapural, M. et al. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res 940, 102–104 (2002).
pubmed: 12020881
doi: 10.1016/S0006-8993(02)02586-6
Rosén, H., Sunnerhagen, K. S., Herlitz, J., Blomstrand, C. & Rosengren, L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 49, 183–191 (2001).
pubmed: 11382525
doi: 10.1016/S0300-9572(00)00348-8
Hasselblatt, M. et al. Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage. Neurology 62, 1634–1636 (2004).
pubmed: 15136701
doi: 10.1212/01.WNL.0000123092.97047.B1
Yende, S. et al. Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials. Crit Care Med 44, 1461–1467 (2016).
pubmed: 26992066
pmcid: 4949079
doi: 10.1097/CCM.0000000000001658
Hughes, C. G. et al. Relationships between markers of neurologic and endothelial injury during critical illness and long-term cognitive impairment and disability. Intensive Care Med 44, 345–355 (2018).
pubmed: 29523900
pmcid: 5870884
doi: 10.1007/s00134-018-5120-1